Medistim ASAOSL: MEDI

MEDI: Record revenue and EBIT margin in 2025, driven by global growth and innovation

· Issued by Medistim ASA

Record 2025 revenue of NOK 700 million and 28% EBIT margin, with strong growth across all regions and segments. Major investments in R&D, new product launches, and expanded direct sales presence position the company for continued global expansion.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Medistim ASA on 6ix

In the deck

Story so far

Earlier from Medistim

Later from Medistim

All Medistim news releases